1. Home
  2. HBNC vs WVE Comparison

HBNC vs WVE Comparison

Compare HBNC & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HBNC
  • WVE
  • Stock Information
  • Founded
  • HBNC 1873
  • WVE 2012
  • Country
  • HBNC United States
  • WVE Singapore
  • Employees
  • HBNC N/A
  • WVE N/A
  • Industry
  • HBNC Major Banks
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • HBNC Finance
  • WVE Health Care
  • Exchange
  • HBNC Nasdaq
  • WVE Nasdaq
  • Market Cap
  • HBNC 826.6M
  • WVE 915.6M
  • IPO Year
  • HBNC N/A
  • WVE 2015
  • Fundamental
  • Price
  • HBNC $16.12
  • WVE $7.09
  • Analyst Decision
  • HBNC Buy
  • WVE Strong Buy
  • Analyst Count
  • HBNC 3
  • WVE 14
  • Target Price
  • HBNC $19.67
  • WVE $20.50
  • AVG Volume (30 Days)
  • HBNC 357.8K
  • WVE 3.6M
  • Earning Date
  • HBNC 10-22-2025
  • WVE 11-10-2025
  • Dividend Yield
  • HBNC 4.00%
  • WVE N/A
  • EPS Growth
  • HBNC N/A
  • WVE N/A
  • EPS
  • HBNC N/A
  • WVE N/A
  • Revenue
  • HBNC N/A
  • WVE $109,230,000.00
  • Revenue This Year
  • HBNC $51.78
  • WVE N/A
  • Revenue Next Year
  • HBNC $7.40
  • WVE $6.24
  • P/E Ratio
  • HBNC N/A
  • WVE N/A
  • Revenue Growth
  • HBNC 1.91
  • WVE 103.75
  • 52 Week Low
  • HBNC $12.70
  • WVE $5.28
  • 52 Week High
  • HBNC $19.18
  • WVE $16.38
  • Technical
  • Relative Strength Index (RSI)
  • HBNC 53.29
  • WVE 43.50
  • Support Level
  • HBNC $15.95
  • WVE $6.72
  • Resistance Level
  • HBNC $16.44
  • WVE $8.08
  • Average True Range (ATR)
  • HBNC 0.34
  • WVE 0.73
  • MACD
  • HBNC 0.04
  • WVE -0.13
  • Stochastic Oscillator
  • HBNC 66.51
  • WVE 17.44

About HBNC Horizon Bancorp Inc.

Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: